2006
DOI: 10.1038/sj.gene.6364313
|View full text |Cite
|
Sign up to set email alerts
|

Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(12 citation statements)
references
References 25 publications
1
10
0
1
Order By: Relevance
“…The +49A/G SNP resulting in an amino acid substitution (Thr17Ala) in the leader peptide causes altered processing in the endoplasmic reticulum and lower surface expression in transected cells (Ligers et al, 2001). In fact, studies found that the CTLA-4 -318C/T polymorphism is associated with the risk of developing several autoimmune diseases and malignancies (Chang et al, 2004;Almasi et al, 2006;Su et al, 2007;Jones et al, 2009). In this study, we demonstrated an association between the -318C/T CTLA-4 polymorphism and RA.…”
Section: Discussionmentioning
confidence: 55%
“…The +49A/G SNP resulting in an amino acid substitution (Thr17Ala) in the leader peptide causes altered processing in the endoplasmic reticulum and lower surface expression in transected cells (Ligers et al, 2001). In fact, studies found that the CTLA-4 -318C/T polymorphism is associated with the risk of developing several autoimmune diseases and malignancies (Chang et al, 2004;Almasi et al, 2006;Su et al, 2007;Jones et al, 2009). In this study, we demonstrated an association between the -318C/T CTLA-4 polymorphism and RA.…”
Section: Discussionmentioning
confidence: 55%
“…Various factors could explain these discrepancies: for instance, differences in genetic background. In fact, the allele frequencies of both polymorphisms for healthy controls reported in these studies are quite different: in our controls the frequency of −318T is 13% and of +49G is 24%, compared to 3·6% and 36·4% in Caucasian (Iran) [19,21], 1·5% and 21·2% in African Americans [20], 5·7% and 37% in Caucasian (USA) [20] and 12·6% and 66·8% in Japanese patients, respectively [22]. Differences in the definition of SSc are possible but unlikely, because all these studies refer to the ACR clinical criteria [23].…”
Section: Discussionmentioning
confidence: 88%
“…Considering its role as a negative regulator of T-cell activation, it comes as no great surprise that the CTLA-4 gene was found to be associated with a variety of autoimmune conditions [134]. The CTLA-4 gene locus was reported to be linked and/or associated with type 1 diabetes mellitus (T1D) [135e 137], asthma [138], Addison's disease [139], myasthenia gravis [140], Sjogren's syndrome [141], systemic lupus erythematosus (SLE) [142], systemic sclerosis [143], ulcerative colitis [144] and with all forms of AITD (GD, HT, and TAbs [123], see below).…”
Section: Ctla-4 Is Associated With Several Autoimmune Conditionsmentioning
confidence: 99%